Novo Nordisk isn’t alone: Sales of Wegovy rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

picture of four wegovy injections lined up (Credit: Michael Siluk—UCG/Universal Images Group via Getty Images)

With growing prescriptions for weight-loss-aiding drugs, companies manufacturing them are making big money.    

The frenzy for the drug has built up in recent months, with weight-loss-aiding drugs like Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Mounjaro being touted as a “miracle.” The effect of that reflects in the money pharma giants behind these drugs have made, owing to soaring demand.